Table 3 CAV3 mutations identified in patients affected by RMD

From: Caveolinopathies: from the biology of caveolin-3 to human diseases

Nt. change

Aa. change

Phenotype

Ref.

N-terminal domain

 c.13InsG/c.114_453del

p.E4fs19X

RMD

Traverso et al46

 c.77G>A

p.R26Q

RMD

Vorgerd et al; Schara et al and Yabe et al68, 73, 79

 c.82C>A

p.P28T

RMD

Van den Bergh et al74

 c.133G>A

p.A45T

RMD

Betz et al66

 c.134C>T

p.A45V

RMD

Betz et al66

 c.136G>A

p.E46K

RMD

Kubisch et al72

 c.140A>C

p.E46A

RMD

Lorenzoni et al71

Scaffolding domain

 c.154A>G

p.S52G

RMD

Dotti et al67

 c.212C>A*

p.W70X

RMD

Ueyama et al45

Membrane-spanning domain

 c.257T>C*

p.L85P

RMD

Kubisch et al70

 c.307_312del

p.F103_F104del

RMD

Bae et al69

  1. Abbreviations: RMD, rippling muscle disease; *, homozygous mutation.